Year |
Citation |
Score |
2019 |
Lemmens T. When a Theoretical Commitment to Broad Physician Aid-in-Dying Faces the Reality of Its Implementation. The American Journal of Bioethics : Ajob. 19: 65-68. PMID 31566495 DOI: 10.1080/15265161.2019.1654026 |
0.342 |
|
2018 |
Lemmens T, Vacaflor CH. Clinical trial transparency in the Americas: the need to coordinate regulatory spheres. Bmj (Clinical Research Ed.). 362: k2493. PMID 30012844 DOI: 10.1136/Bmj.K2493 |
0.364 |
|
2018 |
Axler RE, Miller FA, Lehoux P, Lemmens T. The institutional workers of biomedical science: Legitimizing academic entrepreneurship and obscuring conflicts of interest. Science & Public Policy. 45: 404-415. PMID 29937617 DOI: 10.1093/Scipol/Scx075 |
0.373 |
|
2017 |
Gibson SG, Axler RE, Lemmens T. Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research. Journal of Empirical Research On Human Research Ethics : Jerhre. 1556264617723137. PMID 28818009 DOI: 10.1177/1556264617723137 |
0.371 |
|
2016 |
Kim SY, Lemmens T. Should assisted dying for psychiatric disorders be legalized in Canada? Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. PMID 27328688 DOI: 10.1503/Cmaj.160365 |
0.336 |
|
2015 |
Gibson S, Raziee HR, Lemmens T. Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine. World Medical & Health Policy. 7: 3-27. PMID 25914853 DOI: 10.1002/Wmh3.131 |
0.362 |
|
2014 |
Gibson SG, Lemmens T. Niche markets and evidence assessment in transition: a critical review of proposed drug reforms. Medical Law Review. 22: 200-20. PMID 24841527 DOI: 10.1093/Medlaw/Fwu005 |
0.344 |
|
2014 |
Persaud N, Ringer T, Lemmens T. How can journals respond to threats of libel litigation? Plos Medicine. 11: e1001615. PMID 24667795 DOI: 10.1371/Journal.Pmed.1001615 |
0.403 |
|
2014 |
Lemmens T, Richards BJ. Investigating research and accessing reproductive material. Journal of Bioethical Inquiry. 11: 11-9. PMID 24390617 DOI: 10.1007/S11673-013-9503-2 |
0.391 |
|
2014 |
Lemmens T, Gibson SG. Decreasing the Data Deficit: Improving Post-Market Surveillance in Pharmaceutical Regulation McGill Law Journal. 59: 943-988. DOI: 10.7202/1026134Ar |
0.346 |
|
2013 |
Macklin R, Shepherd L, Dreger A, Asch A, Baylis F, Brody H, Churchill LR, Coleman CH, Cowan E, Dolgin J, Downie J, Dresser R, Elliott C, Epright MC, Feder EK, ... ... Lemmens T, et al. The OHRP and SUPPORT--another view. The New England Journal of Medicine. 369: e3. PMID 23803134 DOI: 10.1056/Nejmc1308015 |
0.343 |
|
2013 |
Lemmens T. Pharmaceutical knowledge governance: a human rights perspective. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 41: 163-84. PMID 23581664 DOI: 10.1111/Jlme.12012 |
0.386 |
|
2013 |
Flood CM, Lemmens T. Introduction: global health challenges and the role of law. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 41: 9-15. PMID 23581653 DOI: 10.1111/Jlme.12001 |
0.339 |
|
2011 |
Krleža-Jeriç K, Lemmens T, Reveiz L, Cuervo LG, Bero LA. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 30: 87-96. PMID 22159656 DOI: 10.1590/S1020-49892011000700013 |
0.406 |
|
2010 |
Stern S, Lemmens T. Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articles. Plos Medicine. 8: e1001070. PMID 21829331 DOI: 10.1179/2047480613Z.000000000164 |
0.345 |
|
2010 |
Lemmens T. Is There A Lack Of Ethical Integrity In Drug Clinical Trials Health Affairs. 29: 1966-1967. DOI: 10.1377/Hlthaff.2010.0542 |
0.315 |
|
2009 |
Krleza-Jerić K, Lemmens T. 7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials. Croatian Medical Journal. 50: 105-10. PMID 19399942 DOI: 10.3325/Cmj.2009.50.105 |
0.426 |
|
2009 |
Goodyear MD, Lemmens T, Sprumont D, Tangwa G. Does the FDA have the authority to trump the Declaration of Helsinki? Bmj (Clinical Research Ed.). 338: b1559. PMID 19383751 DOI: 10.1136/Bmj.B1559 |
0.367 |
|
2008 |
Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA, Juengst ET, Kaye J, Kedes L, Knoppers BM, Lemmens T, et al. Research ethics recommendations for whole-genome research: consensus statement. Plos Biology. 6: e73. PMID 18366258 DOI: 10.1371/Journal.Pbio.0060073 |
0.44 |
|
2008 |
Bouchard RA, Lemmens T. Privatizing biomedical research--a 'third way'. Nature Biotechnology. 26: 31-6. PMID 18183013 DOI: 10.1038/Nbt0108-31 |
0.404 |
|
2007 |
Goodyear MD, Krleza-Jeric K, Lemmens T. The Declaration of Helsinki. Bmj (Clinical Research Ed.). 335: 624-5. PMID 17901471 DOI: 10.1136/Bmj.39339.610000.Be |
0.405 |
|
2006 |
Lemmens T, Miller PB. Regulating the market in human research participants. Plos Medicine. 3: e330. PMID 16866575 DOI: 10.1371/Journal.Pmed.0030330 |
0.463 |
|
2006 |
Emanuel EJ, Lemmens T, Elliot C. Should society allow research ethics boards to be run as for-profit enterprises? Plos Medicine. 3: e309. PMID 16848618 DOI: 10.1371/Journal.Pmed.0030309 |
0.479 |
|
2006 |
De Vries R, Lemmens T. The social and cultural shaping of medical evidence: case studies from pharmaceutical research and obstetric science. Social Science & Medicine (1982). 62: 2694-706. PMID 16376471 DOI: 10.1016/J.Socscimed.2005.11.026 |
0.366 |
|
2006 |
Lemmens T, Elliott C. Research Ethics Boards: Reply from Trudo Lemmens and Carl Elliott. Plos Medicine. 3: 1970-1971. DOI: 10.1371/Journal.Pmed.0030471 |
0.44 |
|
2006 |
Lemmens T, Miller PB. Correction: Regulating the Market in Human Research Participants. Plos Medicine. 3. DOI: 10.1371/Journal.Pmed.0030447 |
0.377 |
|
2006 |
Emanuel EJ, Lemmens T, Elliott C. Correction: Should Society Allow Research Ethics Boards to Be Run As For-Profit Enterprises? Plos Medicine. 3. DOI: 10.1371/Journal.Pmed.0030391 |
0.398 |
|
2004 |
Lemmens T. Leopards in the temple: restoring scientific integrity to the commercialized research scene. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 32: 641-57. PMID 15807352 DOI: 10.1111/J.1748-720X.2004.Tb01969.X |
0.485 |
|
2004 |
Lemmens T. Confronting the conflict of interest crisis in medical research. Monash Bioethics Review. 23: 19-40. PMID 15688510 DOI: 10.1007/Bf03351418 |
0.472 |
|
2004 |
Lemmens T. Piercing the veil of corporate secrecy about clinical trials. The Hastings Center Report. 34: 14-8. PMID 15553393 DOI: 10.2307/3527585 |
0.413 |
|
2004 |
Lemmens T, Sprumont D, Nys H, Singh J, Glass KC. CIOMS' placebo rule and the promotion of negligent medical practice. European Journal of Health Law. 11: 153-74. PMID 15387423 DOI: 10.1163/1571809041457459 |
0.482 |
|
2004 |
Caulfield T, Lemmens T, Kinsella D, McDonald M. Research ethics and the role of the professional bodies: a view from Canada. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 32: 365-8. PMID 15301201 DOI: 10.1111/J.1748-720X.2004.Tb00483.X |
0.376 |
|
2004 |
Waring DWR, Lemmens T. Integrating Values in Risk Analysis of Biomedical Research: The Case for Regulatory and Law Reform University of Toronto Law Journal. 54: 249-290. DOI: 10.1353/Tlj.2004.0012 |
0.347 |
|
2003 |
Lemmens T, Miller PB. The human subjects trade: ethical and legal issues surrounding recruitment incentives. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 31: 398-418. PMID 14626548 DOI: 10.1111/J.1748-720X.2003.Tb00103.X |
0.48 |
|
2002 |
Lemmens T, Miller PB. Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice. The American Journal of Bioethics : Ajob. 2: 14-7. PMID 12189062 DOI: 10.1162/152651602317533550 |
0.378 |
|
2001 |
Lemmens T, Elliott C. Justice for the professional guinea pig. American Journal of Bioethics. 1: 51-53. PMID 11951892 DOI: 10.1162/152651601300169095 |
0.378 |
|
2000 |
Hirtle M, Lemmens T, Sprumont D. A comparative analysis of research ethics review mechanisms and the ICH good clinical practice guideline. European Journal of Health Law. 7: 265-292. PMID 12174854 DOI: 10.1163/15718090020523197 |
0.342 |
|
2000 |
Lemmens T, Freedman B. Ethics Review for Sale? Conflict of Interest and Commercial Research Review Boards Milbank Quarterly. 78: 547-584. PMID 11191449 DOI: 10.1111/1468-0009.00185 |
0.442 |
|
1999 |
Lemmens T, Elliott C. Guinea pigs on the payroll: the ethics of paying research subjects. Accountability in Research. 7: 3-20. PMID 11657561 DOI: 10.1080/08989629908573939 |
0.34 |
|
1997 |
Glass KC, Weijer C, Lemmens T, Palmour RM, Shapiro SH. Structuring the review of human genetics protocols, Part II: diagnostic and screening studies. Irb. 19: 1-13. PMID 11656943 DOI: 10.2307/3564517 |
0.339 |
|
Show low-probability matches. |